Kidney Drug Deal: Dimerix’s Phase 3 DMX-200 gets an exclusive licence with Everest Medicines for Greater China, South Korea and key SEA markets including Singapore, with a US$10m upfront and up to US$330m in milestones plus 10–15% royalties. Local MedTech Push: Murata Electronics Singapore’s KUMIHIMO Tech Camp Singapore invites ASEAN and India MedTech startups (TRL 3+) to co-develop region-ready healthcare tech through 2026. Health Research Funding: 65LAB backs an NUS project developing an airway-delivered biologic for COPD, aiming for pre-clinical progress and potential company creation. Wound Care Breakthrough: Cuprina Holdings’ MEDIFLY Maggots win US FDA 510(k) clearance for debridement of non-healing wounds, driving a sharp stock surge. Biosecurity & AI: Imperial launches a Biosecurity Network of Excellence and announces two NRF-funded Singapore-hosted AI programmes to speed chemistry discovery and improve software reliability. Cybersecurity Buying: A new survey finds 62% of organisations plan to switch or add cybersecurity vendors in the next year, with AI security and identity access among top priorities. EVs & Health Angle: EV adoption keeps accelerating globally, with 63% of new cars electric by May 2026—relevant for air-quality and wellness conversations. Public Health Law Update: Charges against a 25-year-old woman facing Kpod trafficking and vape-related offences were abated after her death.